Company: VSA
Filing Date: 2025-06-16
Form Type: 6-K
Source: 0001104659-25-059696
Chunk: 1

Company: VisionSys AI Inc
Filing Date: 2025-06-16
Form: 6-K
Chunk 1
---
tailored to the client’s specific application needs. The primary target clients include internet technology firms, AI startups,
and e-commerce platforms in Asia.

Our product-based business model is to produce
EEG (electroencephalography) acquisition devices as well as to provide related technical services. The primary target clients are medical
institutions and research institutions in Asia.

We expect to generate revenue from technical services
contract and sales of Brain-Computer Interface (BCI) devices.

Although we are still in the process of product
research and development, we have generated revenue through the provision of technical services.

Risk Factors Relating to Our BCI Business

Regulatory policies in the medical and technology sectors may change in the jurisdictions where we operate.

The development and use of our core algorithms
and related software-hardware systems for brain-computer interfaces may be subject to evolving regulatory requirements, particularly in
the medical and technology sectors. Regulatory policies in the jurisdictions where we currently operate—primarily in Asia—as
well as in potential future markets, may change or become more stringent. Such changes could lead to increased compliance costs, delays
in product development or deployment, or limitations on our ability to commercialize BCI technologies across different regions.

The actual commercialization progress may fall short of expectations, and the market acceptance of our services or products may be limited.

The development and commercialization of our core
algorithms and related software-hardware systems for brain-computer interface (BCI) technologies are subject to significant uncertainty.
Despite ongoing R&D efforts, the actual progress may fall short of expectations due to technical challenges, regulatory hurdles, or
resource constraints. In addition, the market acceptance of BCI-based products and services remains nascent and unproven at scale. If
users, developers, or commercial partners do not adopt our solutions as anticipated, our business prospects, financial performance, and
competitive position could be adversely affected.

Implementation challenges may arise due to the need to integrate complex software and hardware systems, along with user testing, potentially leading to a prolonged development cycle and deviations from forecast assumptions.

Implementation challenges may arise from the need
to integrate complex software and hardware components within our brain-computer interface systems. This process often involves extensive
user testing, iteration, and system optimization, which can lead to a prolonged development cycle. As a result, there may be delays or
deviations from our projected timelines, cost estimates, or performance assumptions, potentially impacting our ability to achieve commercialization
milestones.

The brain-computer interface industry